• Sentieon's 'Faster/Cheaper' Genomics Tools

    Bio-IT World | Sentieon's DNAseq and TNseq software, are making waves in the life sciences, creating a "drop in replacement" that is a faster and cheaper alternative to the industry standard for secondary analysis in next-generation sequencing (NGS) data processing while producing the industry standard results.

    Jun 25, 2019

  • Tracking The Clinical And Preclinical Progress In Targeting Membrane Proteins

    Bio-IT World | G protein-coupled receptors (GPCRs), ion channels, and transporters represent some of the most important drug target classes across a wide range of diseases. According to Catherine Hutchings, progress in targeting these membrane proteins requires a recognition of not only what works, but also what doesn't.

    Jun 24, 2019

  • Officials Say They Lack Authority To Halt CRISPR Babies Plan In Russia

    STAT | Two influential leaders in science for the first time publicly condemned a Russian biologist who said he plans to produce gene-edited babies but conceded that it was beyond their organizations’ authority to halt him from doing so.

    Jun 24, 2019

  • High-Confidence Characterization Of Small Molecule 'Unknowns': How Software Is Enabling Intelligent, High-Resolution Accurate Mass LC-MS/MS Data Acquisition

    Bio-IT World Contributed Commentary | Liquid chromatography-tandem mass spectrometry has proven to be a powerful tool for small molecule analysis. However, the identification of so-called "unknown-unknowns" is extremely challenging.

    Jun 17, 2019

  • Deep Genomics Identifies Rare Disease Targets Using AI System

    Bio-IT World News Brief | Deep Genomics' AI system has identified 1,600 rare disease targets that can be drugged using its splice-switching oligonucleotide technology.

    Jun 14, 2019

  • Biobanking: A Thing Of The Past?

    Bio-IT World | Andrew Brooks, COO at RUCDR Infinite Biologics and Professor of Genetics at Rutgers University, discusses the changes he's seen in biobanking over the last decade, including the rapid changes direct to consumer applications are bringing to research biobanks, and whether or not traditional biobanks are a thing of the past.

    Jun 13, 2019

  • Golden Helix Releases Cancer Add-On To VSClinical

    Bio-IT World News Brief | Golden Helix has announced a cancer addition to their clinical analytics product, VSClinical. This new capability will guide clinicians through the clinical assessment of somatic variants, adding workflows modeled off the guidelines issued by the Association of Molecular Pathologists.

    Jun 10, 2019

  • Organoids And Their Impact On Pre-Clinical Drug Discovery

    Bio-IT World | Pharmaceutical companies are looking for ways to save time and money in the drug discovery process. If there was a way to determine a therapy's impact in the pre-clinical process, researchers would have a better understanding of where to focus their efforts. This is where organoids come in.

    Jun 7, 2019

  • The Future Of Blockchain: The Use Cases Set To Reshape Life Sciences

    Bio-IT World Contributed Commentary | Ever since blockchain burst onto the scene a decade ago, people have continually found new—and sometimes odd—applications for the technology. Yet when it comes to the life sciences, a lack of practical applications has resulted in blockchain being considered a "hammer in search of a nail."

    Jun 5, 2019

  • 2 Chinese Babies With Edited Genes May Face Higher Risk Of Premature Death

    NPR.org | There are new concerns about the world's first genetically modified babies. It appears that the genetic variation a Chinese scientist was trying to recreate when he edited twin girls' DNA may be more harmful than helpful to health overall, according to a study published Monday.

    Jun 3, 2019

  • PerkinElmer Joins Accenture's Open Partner Ecosystem

    Bio-IT World | PerkinElmer has signed on to Accenture's open partner ecosystem and will integrate its big data technology and content into the cloud-based platform's wider efforts in drug discovery and research.

    Jun 3, 2019

  • Grail Outlines Its Plans For A Blood Test To Detect Cancer

    STAT | Could a blood test detect cancer in healthy people? Grail, a Menlo Park, Calif.-based company, has raised $1.6 billion in venture capital to prove the answer is yes.

    May 31, 2019

  • ACD/Labs, Genomenon, Accenture, And More: News From May 2019

    Bio-IT World | May featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including ACD/Labs, Genomenon, Accenture, and more.

    May 30, 2019

  • MGI Sues Illumina for Patent Infringement in the United States

    Bio-IT World News Brief | Complete Genomics Inc., a US subsidiary of MGI, has filed a patent infringement lawsuit against Illumina in US District Court for the District of Delaware.

    May 29, 2019

  • Exploring The Species Near Us

    Bio-IT World | Rob Dunn, Professor of Applied Ecology, North Carolina State University has written an engaging and absorbing account of his adventures in ecology, starting with field work in the remote rain forests of Costa Rica. Eventually he learned he could discover closer to home—and help students identify—previously unknown bacteria and insects in houses, including those living in showerheads and extremophiles living in freezers and ovens.

    May 23, 2019

  • Adimab Team Accuses Prominent MIT Investigator Of Ripping Off Antibodies, Presenting Them As His Own

    Endpoints News | In an opinion paper published yesterday, John Carroll at Endpoints News speaks with Adimab chief Tillman Gerngross and MIT investigator Ram Sasisekharan about Gerngross's recent allegations against Sasisekharan, claiming he has been ripping off the work of others in the antibody field and passing it off as his own design done in silico.

    May 22, 2019

  • New Math Model Could Impact The Study Of Rapidly Evolving Diseases

    Bio-IT World | Researchers at Florida State University have developed a computational model with the potential to change the way researchers approach population genetics and the spread of diseases that evolve quickly in response to different environments.

    May 20, 2019

  • HPE Agrees to Buy Supercomputer Maker Cray for $1.4 Billion

    Bloomberg.com | Hewlett Packard Enterprise Co. has agreed to buy U.S. supercomputer maker Cray Inc. in a deal valued at about $1.4 billion as the firm works to become more competitive in high-end computing.

    May 17, 2019

  • A Bird's Eye View Of Data Consultancies

    Bio-IT World | During a panel discussion at the Bio-IT World Conference & Expo, three data science consultants came together to discuss the intricacies of the industry they so often work with.

    May 16, 2019

  • The Return On Investment Of Healthcare Compliance

    Bio-IT World Contributed Commentary | Healthcare companies, especially in growth phase, must be able to demonstrate the ability to comply with the laws that control their business and to identify fissures in operations quickly. Entrepreneurs and investors should therefore view compliance as a competitive advantage that puts the company in a favorable position to avoid—and swiftly and effectively to tackle—potential regulatory challenges.

    May 15, 2019